Although altered RUNX1 is most commonly associated with AML, there are reports of frequent RUNX1 mutations in blast crisis CML,104,105 and we showed that functional variants in K562 are significantly overrepresented in AML (MLL cohort). This evidence concerns the gene RUNX1 and chronic myelogenous leukemia, BCR-ABL1 positive.